Evidence map›Paper›PMID 40574047›Full record

ArticlePharmaceutics2025

The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate.

Tomasz Pietrzak, Ziemowit Szendzielorz, Joanna Borychowska, Tomasz Ratajczak, Marcin Kubisiak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomasz PietrzakResearch and Development Department, Pharmaceutical Works Polpharma S.A., Pelplińska 19, 83-200 Starogard Gdański, Poland.ORCID 0000-0002-6293-0276
Ziemowit SzendzielorzResearch and Development Department, Pharmaceutical Works Polpharma S.A., Pelplińska 19, 83-200 Starogard Gdański, Poland.
Joanna BorychowskaResearch and Development Department, Pharmaceutical Works Polpharma S.A., Pelplińska 19, 83-200 Starogard Gdański, Poland.
Tomasz RatajczakResearch and Development Department, Pharmaceutical Works Polpharma S.A., Pelplińska 19, 83-200 Starogard Gdański, Poland.ORCID 0000-0002-2605-3368
Marcin KubisiakResearch and Development Department, Pharmaceutical Works Polpharma S.A., Pelplińska 19, 83-200 Starogard Gdański, Poland.

Funding

Zakłady Farmaceutyczne Polpharma S.A.(formerly Polfa Warszawa S.A.) under the Operational Programme Smart Growth for 2014-2020 under Priority Axis:-I Support for R&D activity of enterprises, Measure 1.2. "Sectoral R&D programs INNONEUROPHARM" POIR.01.02.00-00-0018/17
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bead millinghigh-shear homogenizationlong-acting injection (LAI)stabilitysterilization

Identifiers

PMID40574047
PMCPMC12196128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.